Skip to content
2000
Volume 14, Issue 8
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Background: The endogenous cannabinoid system (eCB) has been shown to play an important role in the extinction of aversive memories. AM404, the metabolite of paracetamol, was shown to enhance eCB signaling. Objective: The present study was designed to pre-clinically evaluate the effectiveness of paracetamol against Post-traumatic stress disorder (PTSD). Methods: Contextual Fear conditioning (CFC) was used as animal model of PTSD. The behavioral and biochemical indicators of anxiety were also measured using elevated plus maze (EPM) and corticosterone levels, respectively. Results: Our data showed that the paracetamol treatment (100, 250 and 500 mg/kg) caused significant dose dependent decrease in animal’s freezing behavior in fear conditioned rats. The EPM data revealed that the treated rats spent more time in the open arm of elevated plus maze. However, the corticosterone levels remained unaltered. Conclusion: The present study provide robust evidence that the paracetamol, having established safety in humans, holds promise against PTSD and merits further investigation as potential lead compound in anti-PTSD drug development program.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180814666170203162557
2017-08-01
2025-01-12
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180814666170203162557
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test